Contingencies and commitments - Clinical Trials and Contract Manufacturing Commitments (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
| Contingencies and commitments | |||
| Subcontract costs | $ 41,580,000 | $ 41,505,000 | $ 23,565,000 |
| Clinical trials and contract manufacturing commitments | |||
| Contingencies and commitments | |||
| Other commitments | 25,849,000 | ||
| Other commitments, due within one year | 13,213,000 | ||
| Other commitments, due in one to three years | 12,636,000 | ||
| Subcontract costs | $ 4,158,000,041,505,000 | ||
| X | ||||||||||
- Definition Amount of other commitments maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Amount of other commitments maturing in the second or third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Amount of subcontract costs incurred during the period. No definition available.
|
| X | ||||||||||
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|